对抗治疗物质使用障碍的源控制模型
Matthew Robert Dernbach1, Karen Drexler, Elizabeth McCord
1From the Departments of Emergency Medicine, and Psychiatry and Behavioral Sciences, Emory University, Atlanta, GA.
Journal of addiction medicine
|July 16, 2024
概括
这项研究提出了治疗耐药物使用障碍 (SUD) 的"源控制"模型,将其视为一种疾病. 这种方法旨在消除SUD的耻辱化,并指导创新的多式联络治疗.
科学领域:
- 医学研究 医学研究
- 公共卫生 公共卫生
- 药物中毒药物 药物中毒药物
背景情况:
- 药物使用障碍 (SUD) 提出了复杂的挑战,特别是在治疗耐药的病例中.
- 当前的模型可能无法完全解决严重SUD的多面性质.
- 围绕SUD的耻辱感阻碍了有效的医疗管理和患者护理.
研究的目的:
- 引入并证明"源控制"模式对治疗耐药物使用障碍 (SUD) 的应用.
- 探索这个概念框架如何补充现有的SUD管理策略.
- 通过将SUD视为可管理的疾病来推动SUD的脱而出.
主要方法:
- 从传染病管理中"源控制"模型的概念分析和应用.
- 关于现有的SUD治疗模式和挑战的文献综述.
- 讨论模型的优点,局限性和未来研究的潜力.
主要成果:
- "源控制"模型为理解和管理耐治疗性SUD提供了一个新的框架.
- 这种方法结合了多模式干预和急性/长期护理策略的需求.
- 该模型有可能刺激新的研究方向和治疗创新.
结论:
- 将"源控制"模型应用于SUD可以提高治疗疗效和患者的治疗结果.
- 这种以疾病为中心的观点可以减少与SUD相关的耻辱.
- 该模型为复杂的SUD案件的急性和长期管理提供了统一的方法.
相关概念视频
Substance Use Disorders Affecting Sleep
163
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
163
Drug Abuse and Addiction: Pharmacological Phenomena
459
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
459
Drug Therapy
41
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
41
Drug Dependence
993
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
993
Operant Conditioning Intervention
56
Operant conditioning serves as a foundational principle in therapeutic interventions aimed at modifying maladaptive behaviors. Central to this approach is the notion that behaviors, both adaptive and maladaptive, are learned through reinforcement. By analyzing the environmental factors that reinforce problematic behaviors, clinicians can design interventions to weaken these reinforcements and replace maladaptive behaviors with healthier alternatives.
In operant conditioning, behaviors that are...
In operant conditioning, behaviors that are...
56
Psychosis: Goals of Pharmacotherapy
114
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
114


